Multifactorial Dermatitis in an Elderly Patient with Chronic Actinic Dermatitis: A Case Report
DOI:
https://doi.org/10.19166/med.v14i2.9555Keywords:
Chronic actinic dermatitis, Elderly, Photodermatosis, UV exposureAbstract
Background : Chronic actinic dermatitis (CAD) is a rare, persistent photodermatosis triggered by UV and visible light, primarily affecting elderly individuals. With multifactorial etiologies, including genetic predisposition, environmental exposure, and comorbidities, CAD significantly impacts quality of life. This case report presents an elderly farmer with CAD, emphasizing the complexities of diagnosis and management in individuals exposed to high levels of sunlight due to occupational factors.
Methods : A 70-year-old male farmer presented with a two-week history of pruritus and burning sensations on his face, exacerbated by sun exposure. He had a history of seborrheic dermatitis and hypertension. Physical examination revealed erythematous, hyperpigmented plaques on sun-exposed areas, with macular erythema, erosion, and lichenification. The working diagnosis was CAD, with actinic prurigo and cutaneous T-cell lymphoma as differentials. Management included methylprednisolone, cetirizine, and a compounded cream containing clobetasol propionate and gentamicin. Preventive measures, such as the use of moisturizers, sunblock, and UV avoidance, were also emphasized. The prognosis was favorable for life and function but uncertain for complete remission due to CAD's chronic nature.
Conclusions : This case underscores the importance of an integrated approach combining pharmacological treatment and preventive strategies to manage CAD effectively. Tailored interventions addressing occupational and environmental risk factors are vital. Diagnostic limitations highlight the necessity for follow-up and the development of enhanced diagnostic tools. CAD management requires multidisciplinary collaboration to optimize patient outcomes.
References
1. Zhong J, Ali K, Yang P, Zhao X, Wu L. Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib. CCID. 2024 Feb; 2024(17):399–407. https://doi.org/10.2147/CCID.S451824
2. Paek SY, Lim HW. Chronic actinic dermatitis. Dermatol Clin. 2014 Jul;32(3):355–61, viii–ix. https://doi.org/10.1016/j.det.2014.03.007
3. Scherrer MAR, Ribeiro MD, Lopes Dos Anjos HB, Rocha VB. Chronic actinic dermatitis: a retrospective study of epicutaneous and photo epicutaneous tests between 2007‒2023. Anais Brasileiros de Dermatologia. 2025 Jan-Feb;100(1):148-150. https://doi.org/10.1016/j.abd.2024.03.011
4. Sekar C S. Chronic actinic dermatitis. IJSA. 2024 Apr 18;3:41–4. https://skinallergyjournal.com/chronic-actinic-dermatitis/
5. Chaiyabutr C, Dawe R, Lesar A, Ibbotson SH. A retrospective comparison of early- and late-onset chronic actinic dermatitis: characteristics and management. Br J Dermatol. 2024 May 17;190(6):923–5. https://doi.org/10.1093/bjd/ljae101
6. Sasmithae L, Perdana I. A Rare and Fatal Case of Cutaneous T-Cell Lymphoma (CTCL). Indonesian Journal of Cancer. 2021 Oct 22;15(3):148. https://doi.org/10.33371/ijoc.v15i3.803
7. Gu Q, Zhang Z, Yang J, Gao H, Hu Y, Xu Y, et al. Chronic actinic dermatitis: A 5-year clinical analysis of 488 patients in China. Photodermatol Photoimmunol Photomed. 2023 May;39(3):263–8. https://doi.org/10.1111/phpp.12835
8. Wang CX, Belsito DV. Chronic Actinic Dermatitis Revisited. Dermatitis. 2020;31(1):68–74. https://doi.org/10.1097/der.0000000000000531
9. Gabros S, Nessel TA, Zito PM. Topical Corticosteroids. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Dec 11]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532940/
10. Ali K, Wu L, Lou H, Zhong J, Qiu Y, Da J, et al. Clearance of Chronic Actinic Dermatitis with Dupilumab Therapy in Chinese Patients: A Case Series. Front Med. 2022 Feb 24; 9:803692. https://doi.org/10.3389/fmed.2022.803692
11. Chew A, Bashir SJ, Hawk JL, Palmer R, White IR, McFadden JP. Contact and photocontact sensitization in chronic actinic dermatitis: a changing picture. Contact Dermatitis. 2010 Jan;62(1):42–6. https://doi.org/10.1111/j.1600-0536.2009.01658.x
12. Reinehr CPH, Bakos RM. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects. An Bras Dermatol. 2019;94(6):637–57. https://doi.org/10.1016/j.abd.2019.10.004
13. Lim HW, Morison WL, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis. An analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol. 1994 Oct;130(10):1284–9. https://doi.org/10.1001/archderm.130.10.1284
14. Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, et al. Chronic Pruritus: A Review. JAMA. 2024 Jun 25;331(24):2114. https://doi.org/10.1001/jama.2024.4899
15. Chaves BJ, Tadi P. Gentamicin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Dec 11]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557550/
16. Chavda VP, Acharya D, Hala V, Daware S, Vora LK. Sunscreens: A comprehensive review with the application of nanotechnology. Journal of Drug Delivery Science and Technology. 2023 Sep; 86:104720. http://dx.doi.org/10.1016/j.jddst.2023.104720
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
